share_log

NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

neogenomics将在AMP 2024上展示四项研究,展示ctDNA和NGS在癌症诊断和个性化治疗方面的进展。
Benzinga ·  11/19 08:19

Highlights Include Solid Tumor Profiling, Liquid Biopsy Sensitivity, And HPV Subtyping Innovations

亮点包括实体肿瘤分析、液体活检灵敏度和HPV分型创新

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发